TNYA Research and Charts

TNYA - Tenaya Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-07-11)

Last 0.68	Change ⇓ -0.01 (0.00%)	Volume 1,812,557
	Open 0.68	High 0.71	Low 0.67

8EMA (Daily) 0.65	40EMA (Daily) 0.59	50EMA (Daily) 0.60	STO (Daily) 67.721	MACD Hist (Daily) 0.009
8EMA (Weekly) 0.598	40EMA (Weekly) 1.22	50EMA (Weekly) 1.46	STO (Weekly) 65.641	MACD Hist (Weekly) 0.169


Company Profile
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.